112 related articles for article (PubMed ID: 342081)
1. Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas.
Mattsson W; von Eyben F; Turesson I; Wählby S
Cancer; 1978 Jan; 41(1):112-6. PubMed ID: 342081
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087).
Aungst CW; Mittelman A; Murphy GP
J Surg Oncol; 1975; 7(6):457-60. PubMed ID: 1102806
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma.
Johnsson JE; Tropé C; Mattsson W; Grundsell H; Aspegren K; Könyves I
Cancer Treat Rep; 1979 Mar; 63(3):421-4. PubMed ID: 371798
[TBL] [Abstract][Full Text] [Related]
4. Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031).
Håkansson L; Könyves I; Lindberg LG; Möller T
Oncology; 1978; 35(3):103-6. PubMed ID: 673314
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
[TBL] [Abstract][Full Text] [Related]
6. Prednimustine treatment in malignant lymphomas.
Szántó I; Fleischmann T; Eckhardt S
Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
[TBL] [Abstract][Full Text] [Related]
8. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
Biomedicine; 1977 Jun; 27(4):158-61. PubMed ID: 329910
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT
Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470
[TBL] [Abstract][Full Text] [Related]
10. Comparison of chlorambucil and streptonigrin (NSC-45383) in the treatment of malignant lymphomas.
Kaung DT; Wittington RM; Spencer H; Patno ME
Cancer; 1969 Jun; 23(6):1280-3. PubMed ID: 4890442
[No Abstract] [Full Text] [Related]
11. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.
Móller TR; Brandt L; Kónyves I; Lindberg G
Acta Med Scand; 1975 Apr; 197(4):323-7. PubMed ID: 1173538
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
[TBL] [Abstract][Full Text] [Related]
13. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
Lutz D; Böhnel J
Osterr Z Onkol; 1977; 3(5-6):155-9. PubMed ID: 323777
[TBL] [Abstract][Full Text] [Related]
15. [Prednimustine in treatment of acute leukemia in elderly patients].
Brandt L; Könyves I
Lakartidningen; 1977 Apr; 74(15):1490-3. PubMed ID: 321896
[No Abstract] [Full Text] [Related]
16. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
Loos U; Musch E; Malek M; Riedel E
Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
[TBL] [Abstract][Full Text] [Related]
17. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316
[TBL] [Abstract][Full Text] [Related]
18. Preliminary clinical study of prednimustine in lung cancer.
Catane H; Catane R; Takita H; Kaufman JH; Mittelman A; Murphy GP
J Med; 1977; 8(2):115-21. PubMed ID: 268397
[TBL] [Abstract][Full Text] [Related]
19. Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
Gandara DR; Wold HG; Redmond J; Kohler M; Reynolds R; Wong P; Forsythe J; Fisher K; Lewis B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):14-8. PubMed ID: 3952517
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester, in lymphoproliferative disorders. I. chronic lymphocytic leukaemia.
Brandt L; Kónyves I; Móller TR
Acta Med Scand; 1975 Apr; 197(4):317-22. PubMed ID: 1136862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
